# Lung Stent Market

> Lung Stent Market Research Report: Size, Share, Trend Analysis By Applications (Bronchial Stenting, Tracheal Stenting, Esophageal Stenting), By Material (Metal Stents, Polymer Stents, Coated Stents), By Procedure Type (Endoscopic Procedure, Surgical Procedure), By Distribution Channel (Hospital, Ambulatory Surgical Centers, Specialty Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.57%
- **2024:** $ 2.05 Billion
- **2025:** $ 2.18 Billion
- **2035:** $ 4.12 Billion
- **Key Players:** Boston Scientific (US), Medtronic(US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cook Medical (US), Terumo Corporation (JP), Stentys (FR), MediGlobe AG (DE), Stryker Corporation (US)

**Report ID:** MRFR/HC/31266-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/lung-stent-market-33081

---

## Market Summary

## **Lung Stent Market Overview**

As per MRFR analysis, the Lung Stent Market Size was estimated at 2.05 (USD Billion) in 2024. The Lung Stent Market Industry is expected to grow from 2.18 (USD Billion) in 2025 to 3.87 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.57% during the forecast period (2025 - 2034).

### **Key Lung Stent Market Trends Highlighted**

The Lung Stent Market is experiencing significant growth driven by an increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer. Advances in medical technology, including the development of innovative stent designs and materials, are enhancing treatment options and improving patient outcomes. Additionally, an aging population and rising awareness around minimally invasive procedures are propelling demand for lung stents. The growing number of hospitals and specialty clinics equipped to perform these procedures contributes further to market expansion, creating a robust environment for lung stent adoption.

There are substantial opportunities within the market yet to be fully explored. Regions with developing healthcare infrastructure present significant potential for growth. Manufacturers targeting these regions can provide training and education to healthcare professionals, promoting the benefits of lung stents. Partnerships with local healthcare providers can further facilitate market entry. Another promising avenue is the integration of smart technology into lung stents, offering enhanced patient monitoring and improved outcomes. Developing regions are also seeing a shift towards advanced healthcare facilities, increasing the demand for effective stenting solutions.

In recent times, there has been a trend towards personalization in medical devices, including lung stents. This shift is leading to the customization of stents based on individual patient anatomy and needs. Moreover, increased focus on clinical studies and research is paving the way for evidence-based approaches to lung stenting, fostering confidence among healthcare providers and patients alike. The rise of telemedicine is also impacting how treatment options are discussed and implemented, expanding access to specialty care. As these trends continue to evolve, they are shaping the future landscape of the lung stent market, offering prospects for growth and innovation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Lung Stent Market Drivers**

### **Increasing Prevalence of Respiratory Diseases**

The Lung Stent Market Industry is significantly driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and other obstructive pulmonary conditions. With an increasing percentage of the population affected by these conditions, the demand for effective medical interventions has surged. Lung stents serve as essential medical devices that help alleviate airway obstruction, enabling patients to breathe more easily.

The growing incidence of respiratory ailments, fueled by factors like air pollution, smoking, and an aging population, tends to multiply the need for advanced treatments, thus propelling the Lung Stent Market forward. Furthermore, rising public awareness about respiratory health and the availability of improved diagnostic techniques have led to earlier detection of related diseases, encouraging timely treatment interventions. These developments further enhance the need for lung stents, making them pivotal in managing diverse respiratory issues.

Health authorities worldwide are focusing on strategies to combat these diseases while increasing investment in research and development. This competitive environment is creating opportunities for innovations in stent technology, leading to better design, materials, and patient outcomes. The expanding pipeline of clinical studies focusing on lung stent efficacy and safety assures healthcare providers and patients of reliable treatment options. As the understanding of respiratory health continues to evolve, the Lung Stent Market is positioned for robust growth.

### **Technological Advancements in Lung Stent Design**

The Lung Stent Market Industry is witnessing significant growth thanks to technological advancements in the design and manufacturing of lung stents. Innovative materials and designs have improved the effectiveness, flexibility, and biocompatibility of these devices. Modern lung stents come with features that enhance patient comfort and reduce the risk of complications, such as tissue ingrowth and stent migration. Advanced imaging techniques and minimally invasive procedures associated with lung stenting have made it easier for clinicians to deploy stents accurately, improving patient outcomes.

### **Increasing Healthcare Expenditures**

An increase in global healthcare expenditures is contributing significantly to the growth of the Lung Stent Market Industry. As governments and private sectors invest more in healthcare infrastructure and services, the availability of medical treatments, including lung stenting procedures, is improving. Increased budget allocations are being directed towards respiratory health, promoting the development and delivery of essential medical devices.

This trend encompasses the expansion of hospitals, clinics, and specialized facilities offering comprehensive care for patients with respiratory complications. Additionally, consumers are becoming more willing to spend on advanced healthcare solutions, improving overall access to vital treatments and therapies. With growing support from the healthcare sector, the Lung Stent Market outlook appears promising.

## **Lung Stent Market Segment Insights:**

### **Lung Stent Market Application Insights  **

Within the Application segment, the market is segmented into Bronchial Stenting, Tracheal Stenting, and Esophageal Stenting. Among these divisions, Bronchial Stenting holds a majority with a valuation of 0.72 USD Billion in 2023, and it is expected to grow to 1.25 USD Billion by 2032.

This growth reinforces its dominance in the market, as bronchial stents are critical for managing airway obstruction in patients with conditions such as lung cancer, chronic obstructive pulmonary disease (COPD), and other diseases that affect breathing. Tracheal Stenting, valued at 0.54 USD Billion in 2023 and anticipated to reach 0.95 USD Billion in 2032, also plays an essential role in addressing tracheal obstruction, thus illustrating its significance in treating life-threatening conditions affecting the airway.

Esophageal Stenting, meanwhile, is valued at 0.55 USD Billion in 2023 with an expected rise to 0.9 USD Billion by 2032; it is increasingly relied upon in the management of esophageal cancers and strictures, further highlighting its critical importance for patients facing swallowing difficulties.

The notable growth in these areas reflects the rising prevalence of related diseases and the demand for effective stenting solutions. The trends within the Lung Stent Market indicate not only a growing need for these medical devices but also opportunities for innovation that can enhance patient outcomes, although challenges persist, including regulatory hurdles and potential complications. The overall Lung Stent Market data presents a compelling picture of a sector poised for growth, as the continual improvements and advancements in lung stent technologies aim to address the increasing complexity of managing severe respiratory conditions across various segments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Lung Stent Market Material Insights **

The Lung Stent Market, valued at 1.81 billion USD in 2023, showcases significant growth potential within the Material segment, which includes Metal Stents, Polymer Stents, and Coated Stents. The market is driven by an increasing prevalence of respiratory disorders, leading to rising demand for effective treatment options. Metal Stents currently dominate the market due to their strength and durability, providing enhanced support for airway patency. Conversely, Polymer Stents are gaining traction, especially for their flexible nature and biocompatibility, making them suitable for various patient needs.

Coated Stents hold a significant share as they can be engineered to promote specific therapeutic effects, reducing complications post-implantation. The Lung Stent Market data reveals that these materials contribute to advancements in patient care, enhancing the effectiveness of lung stenting procedures. The overall market is poised for growth, attributed to innovations in stent technology and increasing awareness of lung diseases, positioning it as a vital segment in the Lung Stent Market industry. Market trends point towards the continuous evolution of stent designs that aim to improve patient outcomes while addressing unique clinical challenges.

### **Lung Stent Market Procedure Type Insights **

The Lung Stent Market, valued at approximately 1.81 billion USD in 2023, is witnessing significant growth driven by advancements in both endoscopic and surgical procedures. The segment of Procedure Type plays a crucial role in the overall market dynamics, as procedures directly impact patient outcomes and clinician efficiency. Within this segment, endoscopic procedures are critical due to their minimally invasive nature, reducing recovery time and hospital stays, hence becoming increasingly preferred in clinical settings. Surgical procedures, meanwhile, remain significant for complex cases where endoscopic approaches may not suffice, offering vital solutions that ensure improved airways and lung function.

Overall, the Lung Stent Market revenue is bolstered by the rising prevalence of respiratory diseases, technological innovations, and a growing geriatric population. Market growth is further supported by increasing awareness among healthcare professionals regarding the effectiveness of these procedures, although challenges exist from reimbursement policies and regulatory hurdles. Despite obstacles, the opportunities for growth are substantial, particularly in developing regions where access to advanced lung stent technologies is expanding.

### **Lung Stent Market Distribution Channel Insights **

The Lung Stent Market revenue is expected to witness substantial growth through various distribution channels, with hospitals playing a pivotal role in delivering lung stent procedures. Hospitals are typically equipped with state-of-the-art facilities and specialized medical teams, contributing to their dominance in this market segment. Ambulatory Surgical Centers have gained traction for providing efficient and less invasive procedures, appealing to a broader patient demographic seeking optimal care and convenience. Additionally, Specialty Clinics cater specifically to lung-related ailments, establishing themselves as significant players due to their concentrated expertise, which enhances patient trust and outcomes.

Growth drivers in the industry include an increasing prevalence of respiratory diseases and technological advancements in lung stent designs, fostering market growth. However, challenges like regulatory compliance and high treatment costs may hinder progress. Despite these hurdles, opportunities for collaboration between healthcare providers and innovative startups are on the rise, promoting developments in the distribution landscape. Overall, the Lung Stent Market statistics reveal a promising trajectory as each distribution channel continues to adapt and thrive in a competitive healthcare environment.

### **Lung Stent Market Regional Insights **

The Lung Stent Market revenue shows substantial growth across various regions, with North America leading the way with a valuation of 0.84 USD Billion in 2023, increasing to 1.51 USD Billion in 2032, thus demonstrating its majority holding in the market. Europe follows closely, valued at 0.54 USD Billion in 2023 and expected to rise to 0.97 USD Billion by 2032, reflecting its significant role in the Lung Stent Market industry. The APAC region, while smaller in comparison, shows potential with a market valuation of 0.31 USD Billion in 2023, projected to reach 0.45 USD Billion by 2032.

South America and MEA are currently less dominant, with respective values of 0.07 USD Billion and 0.05 USD Billion in 2023, projected to grow to 0.14 USD Billion and 0.09 USD Billion. The majority focus in North America can be attributed to advanced healthcare infrastructure and the increasing prevalence of lung diseases, driving market growth. Europe's robust regulatory framework also encourages innovation and adoption of lung stents, while the APAC region is gradually gaining traction due to rising healthcare expenditures and expanding patient access.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Lung Stent Market Key Players and Competitive Insights:**

The Lung Stent Market has seen significant growth in recent years, driven by advancements in technology, increased prevalence of lung diseases, and an expanding senior population. This market is characterized by intense competition among various players striving to differentiate their products through innovation, quality, and customer service. Generally, companies are focusing on expanding their product portfolios and investing in research and development to offer more effective and safer stent solutions. Furthermore, improving healthcare infrastructure and increasing healthcare expenditure in emerging economies are anticipated to fuel the market demand.

Key trends such as the shift towards minimally invasive procedures also influence competitive dynamics, pushing manufacturers to enhance their technological capabilities and streamline their operations.

Cook Medical has established a strong presence in the Lung Stent Market with its innovative approach to product development and commitment to quality. The company's extensive experience in medical device manufacturing allows it to leverage advanced technologies, which results in the production of stents that are highly effective in treating various lung conditions. Cook Medical positions itself well in the market by emphasizing reliability and efficacy, thereby gaining the trust of healthcare professionals. The company's robust distribution network ensures accessibility of its products across multiple geographies, which enhances its market footprint.

In addition, Cook Medical's focus on patient-centered solutions fosters strong relationships with clinicians, ultimately contributing to better health outcomes and solidifying its competitive advantage.

Inari Medical operates within the Lung Stent Market with a distinctive focus on developing specialized devices for treating pulmonary conditions. The company's commitment to innovation is evident in its investment in research and development, which allows it to stay ahead in the competitive landscape. Inari Medical offers a range of products designed to meet the evolving needs of patients and healthcare providers, further enhancing its appeal in the market. The company prides itself on its ability to deliver advanced technology solutions that improve procedural efficiency and patient outcomes.

Inari Medical's strategic partnerships and collaborations with healthcare institutions provide it with valuable insights into market demands, allowing the company to refine its offerings and maintain strong competitive positioning within the lung stent sector.

### **Key Companies in the Lung Stent Market Include:**

- [Cook Medical](https://www.cookmedical.com/products/)
- Inari Medical
- Hudson RCI
- Boston Scientific
- EndoChoice
- Baxa Corporation
- Medtronic
- Abbott Laboratories
- Teleflex
- Stryker
- ConvaTec
- Bard Medical
- Vascular Solutions
- Z-Medica
- Jude Medical

## Lung Stent Industry Developments

- **Q2 2024: Boston Scientific Announces FDA Approval of the AEROmini® Tracheobronchial Stent** Boston Scientific received FDA approval for its AEROmini® Tracheobronchial Stent, expanding its portfolio of minimally invasive airway management solutions for patients with tracheobronchial strictures.
- **Q1 2024: Merit Medical Systems Launches New Endotek® Silicone Airway Stent in the United States** Merit Medical Systems announced the commercial launch of its new Endotek® Silicone Airway Stent, designed to provide improved airway patency for patients with central airway obstruction.
- **Q2 2024: Taewoong Medical Receives CE Mark for Niti-S™ Tracheobronchial Stent** Taewoong Medical announced it has received CE Mark approval for its Niti-S™ Tracheobronchial Stent, allowing the product to be marketed and sold in the European Union.
- **Q2 2024: Cook Medical Announces Partnership with Medtronic to Distribute Airway Stent Portfolio in Asia-Pacific** Cook Medical entered into a distribution partnership with Medtronic to expand the reach of its airway stent products in the Asia-Pacific region.
- **Q1 2024: Micro-Tech Launches Next-Generation Covered Airway Stent in Europe** Micro-Tech (Nanjing) Co., Ltd. announced the European launch of its next-generation covered airway stent, designed for improved patient comfort and easier deployment.
- **Q2 2024: Boston Scientific Opens New Manufacturing Facility for Airway Stents in Ireland** Boston Scientific opened a new manufacturing facility in Ireland dedicated to the production of airway stents, aiming to meet growing global demand.
- **Q1 2024: Merit Medical Systems Appoints New Vice President of Airway Stent Division** Merit Medical Systems announced the appointment of a new Vice President to lead its Airway Stent Division, focusing on global expansion and innovation.
- **Q2 2024: Taewoong Medical Signs Distribution Agreement with Olympus for Lung Stent Products in Japan** Taewoong Medical signed a distribution agreement with Olympus to market and distribute its lung stent products in Japan.
- **Q1 2024: Cook Medical Receives FDA Clearance for Evolution® Biliary Stent for Airway Applications** Cook Medical received FDA clearance to market its Evolution® Biliary Stent for use in airway applications, expanding its therapeutic indications.
- **Q2 2024: Micro-Tech Announces $20 Million Investment to Expand Airway Stent Production Capacity** Micro-Tech (Nanjing) Co., Ltd. announced a $20 million investment to expand its airway stent production capacity at its main manufacturing site.

## **Lung Stent Market Segmentation Insights**

### **Lung Stent Market Application Outlook**

- Bronchial Stenting
- Tracheal Stenting
- Esophageal Stenting

### **Lung Stent Market Material Outlook**

- Metal Stents
- Polymer Stents
- Coated Stents

### **Lung Stent Market Procedure Type Outlook**

- Endoscopic Procedure
- Surgical Procedure

### **Lung Stent Market Distribution Channel Outlook**

- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics

### **Lung Stent Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Growing Focus on Preventive Healthcare

There is a notable shift towards preventive healthcare, which is impacting the Lung Stent Market. As awareness of lung health increases, more individuals are seeking early diagnosis and treatment for respiratory issues. This proactive approach is likely to lead to an uptick in procedures involving lung stents, as patients and healthcare providers prioritize interventions that can prevent disease progression. Furthermore, public health initiatives aimed at reducing smoking rates and improving air quality are expected to contribute to a healthier population, thereby influencing the demand for lung stents. The Lung Stent Market may see growth as a result of this evolving healthcare landscape.

### Rising Incidence of Respiratory Diseases

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a primary driver of the Lung Stent Market. According to recent data, respiratory diseases account for a significant portion of global morbidity and mortality. The World Health Organization indicates that COPD alone affects millions worldwide, leading to a growing demand for effective treatment options. Lung stents are increasingly recognized for their role in managing airway obstructions, thereby enhancing patient quality of life. As healthcare providers seek innovative solutions to address these challenges, the Lung Stent Market is likely to experience substantial growth, driven by the need for advanced therapeutic interventions.

### Technological Innovations in Stent Design

Technological advancements in stent design and materials are transforming the Lung Stent Market. Innovations such as drug-eluting stents and bioresorbable materials are enhancing the efficacy and safety of lung stenting procedures. These advancements not only improve patient outcomes but also reduce the risk of complications associated with traditional stents. The introduction of minimally invasive techniques has further propelled the adoption of lung stents, as they offer quicker recovery times and less postoperative discomfort. As manufacturers continue to invest in research and development, the Lung Stent Market is poised for growth, with new products entering the market that cater to diverse patient needs.

### Regulatory Support for Innovative Medical Devices

Regulatory bodies are increasingly supporting the development and approval of innovative medical devices, including lung stents, which is a key driver for the Lung Stent Market. Streamlined approval processes and incentives for manufacturers to develop advanced stenting solutions are fostering a conducive environment for market growth. This regulatory support not only accelerates the introduction of new products but also enhances patient access to cutting-edge treatments. As regulations evolve to accommodate technological advancements, the Lung Stent Market is likely to expand, driven by a continuous influx of innovative solutions that address unmet medical needs.

### Aging Population and Increased Healthcare Expenditure

The aging population is a significant factor influencing the Lung Stent Market. As individuals age, the likelihood of developing respiratory conditions increases, leading to a higher demand for lung stenting procedures. Additionally, rising healthcare expenditure in many regions is facilitating access to advanced medical technologies, including lung stents. According to recent statistics, healthcare spending is projected to rise, allowing for better investment in respiratory care. This trend suggests that the Lung Stent Market will benefit from an expanding patient base and increased funding for innovative treatment options, ultimately driving market growth.

## Future Outlook

The Lung Stent Market is projected to grow at a 6.57% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of respiratory diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of biodegradable lung stents for enhanced patient safety. Expansion into emerging markets with tailored product offerings. Integration of telemedicine for remote monitoring of stent patients.

By 2035, the Lung Stent Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Application: Bronchial Stenting (Largest) vs. Tracheal Stenting (Fastest-Growing)

In the Lung Stent Market, the application segment is primarily dominated by bronchial stenting, reflecting its significant importance in treating obstructive pulmonary conditions. Bronchial stenting accounts for a large share due to its efficacy in managing patients with severe airway complications, often associated with lung cancer and chronic bronchitis. Tracheal stenting and esophageal stenting follow, though with smaller proportions of market share as they cater to more specific patient needs and conditions. The growth trends in this segment reveal a robust inclination toward bronchial stenting, which stands as the predominant choice among healthcare providers. However, tracheal stenting is recognized as the fastest-growing area, driven by an increase in respiratory disorders and advancements in stent technology for improved patient outcomes. The demand for minimally invasive procedures is a strong growth driver across the board.

Bronchial Stenting (Dominant) vs. Tracheal Stenting (Emerging)

Bronchial stenting is the dominant application in the Lung Stent Market, characterized by its widespread use in managing airway obstructions, particularly in patients battling lung cancer and other pulmonary ailments. The design of bronchial stents allows for excellent airflow and reduced complications, which maintains its status as the preferred choice among clinicians. In contrast, tracheal stenting is emerging as a significant segment, boasting innovations that enhance stent flexibility and ease of placement. While tracheal stents were traditionally limited to select patient populations with severe airway strictures, advancements in design and biocompatibility are paving the way for broader acceptance and increased usage in various clinical settings.

### By Material: Metal Stents (Largest) vs. Polymer Stents (Fastest-Growing)

In the Lung Stent Market, Metal Stents currently hold the largest share, owing to their proven reliability and strength. These stents are extensively used due to their ability to provide long-term support in the bronchial passages. Polymer Stents, on the other hand, are emerging rapidly, catering particularly to patient needs for flexible and biocompatible options. The differentiation in material properties plays a crucial role in their usage across various patient demographics and clinical requirements.

Metal Stents (Dominant) vs. Polymer Stents (Emerging)

Metal Stents are widely recognized for their robustness and durability, making them the dominant choice in the Lung Stent Market. Their structural integrity ensures effective airflow, which is crucial for patients with restrictive airway issues. Conversely, Polymer Stents are quickly gaining traction as an emerging alternative. They are designed to offer enhanced compatibility with the body and reduced risk of tissue reaction. As the healthcare sector emphasizes personalized treatment experiences, Polymer Stents’ versatility and gentle nature towards body tissues are likely to position them favorably in the future of lung interventions.

### By Procedure Type: Endoscopic Procedure (Largest) vs. Surgical Procedure (Fastest-Growing)

In the Lung Stent Market, the procedure type segment is primarily composed of Endoscopic and Surgical Procedures. Currently, Endoscopic Procedures command a significant share of the market, favored for their minimally invasive nature and effectiveness in treating various pulmonary conditions. Surgical Procedures, while traditionally more invasive, are increasingly adopted, offering solutions for complex cases that cannot be addressed by endoscopic methods. This distribution highlights the preference for less invasive solutions among patients and healthcare providers. Looking at growth trends, Endoscopic Procedures are expected to maintain their dominant position as technological advancements enhance their efficacy and safety. Conversely, Surgical Procedures are gaining traction, driven by the rising prevalence of severe pulmonary diseases and innovations that facilitate better patient outcomes. This combination of stability for endoscopic techniques and rapid growth in surgical methods reflects the evolving landscape of the Lung Stent Market, where providers are seeking a balance between innovation and patient care.

Endoscopic Procedure: Dominant vs. Surgical Procedure: Emerging

Endoscopic Procedures represent the dominant segment within the Lung Stent Market, renowned for their minimally invasive approach which significantly reduces recovery times and complications for patients. These procedures are increasingly preferred due to their ability to address a wide array of pulmonary issues with fewer risks. In contrast, Surgical Procedures are emerging as a vital alternative, particularly in cases where endoscopic options are limited. The development of advanced surgical techniques and technologies has made these procedures faster and more efficient, catering to patients with more complicated conditions. While Endoscopic Procedures lead in market share, the rapid innovation in surgical methods positions them as a growing force in the market, highlighting the diverse preferences among healthcare professionals when selecting treatment options.

### By Distribution Channel: Hospital (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Lung Stent Market, distribution channels are primarily segmented into Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics. Hospitals dominate this landscape, capturing the largest share due to their comprehensive facilities and capacity to perform complex surgeries. ASCs are rapidly gaining traction, fueled by a shift towards outpatient services, while specialty clinics offer targeted treatments, although they hold a smaller market share compared to the other two channels.

Hospital (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals play a crucial role in the Lung Stent Market, functioning as the dominant distribution channel. They benefit from a broad patient base and advanced infrastructure, allowing them to provide critical care in various lung-related procedures. Ambulatory Surgical Centers, however, represent an emerging force in this market, driven by the demand for minimally invasive surgeries and shorter recovery times. ASCs are favored by patients seeking quicker procedures with lower associated risks. Specialty Clinics, while valuable for focused treatments, face limitations in terms of patient reach and service diversity in comparison to the broader capabilities of hospitals and the evolving offerings of ASCs.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for lung stents, accounting for approximately 45% of the global share in the global lung stents market. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of respiratory diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies in lung stenting. The United States is the primary contributor to this market, with key players such as Boston Scientific, Medtronic, and Abbott Laboratories leading the competitive landscape. The presence of these major companies fosters a robust environment for technological advancements and product launches. Additionally, the growing awareness of lung health and the rising number of minimally invasive procedures are expected to bolster market growth in the coming years.

### Europe : Emerging Market with Potential

Europe is witnessing significant growth in the lung stent market, holding approximately 30% of the global share. The region benefits from a well-established healthcare system, increasing investments in medical technology, and a rising incidence of chronic respiratory diseases. Regulatory frameworks, such as the European Medical Device Regulation (MDR), are enhancing product safety and efficacy, thereby boosting market confidence. Leading countries in this region include Germany, France, and the UK, where companies like B. Braun Melsungen AG and Stentys are making substantial contributions. The competitive landscape is characterized by a mix of established players and innovative startups, driving advancements in lung stent technology. Collaborative efforts between healthcare providers and manufacturers are also fostering growth, ensuring that patients have access to the latest treatment options.

### Asia-Pacific : Rapidly Growing Market

Asia-Pacific is emerging as a significant player in the lung stent market, accounting for about 20% of the global share. The region's growth is fueled by increasing healthcare expenditure, a rising geriatric population, and a growing prevalence of respiratory diseases. Governments are also implementing favorable policies to enhance healthcare access, which is expected to drive demand for lung stents in the coming years. Countries like Japan, China, and India are at the forefront of this growth, with key players such as Terumo Corporation and Cook Medical actively participating in the market. The competitive landscape is evolving, with both multinational corporations and local manufacturers striving to innovate and capture market share. The increasing focus on minimally invasive procedures is further propelling the demand for advanced lung stent solutions.

### Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually developing in the lung stent market, holding approximately 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of respiratory health, and a growing burden of chronic diseases. Governments are focusing on improving healthcare infrastructure, which is expected to create new opportunities for lung stent adoption in the region. Countries like South Africa and the UAE are leading the market, with a mix of local and international players. The competitive landscape is characterized by a growing number of partnerships and collaborations aimed at enhancing product offerings. As healthcare systems evolve, the demand for innovative lung stent solutions is anticipated to rise, providing significant growth potential for market players.

## Competitive Benchmarking

The Lung Stent Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for minimally invasive procedures and advancements in stent technology. Key players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Boston Scientific (US) focuses on innovation, particularly in drug-eluting stents, while Medtronic (US) emphasizes strategic partnerships to expand its product offerings. Abbott Laboratories (US) is leveraging its strong research and development capabilities to introduce next-generation stents, thereby positioning itself as a leader in the market. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological advancement and patient-centric solutions. In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. The Lung Stent Market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive innovation. This competitive structure allows for a diverse range of products, catering to various patient needs and preferences, while also fostering an environment ripe for collaboration and strategic alliances. In August 2025, Medtronic (US) announced a partnership with a leading [telehealth](https://www.marketresearchfuture.com/reports/telehealth-market-900)provider to integrate remote monitoring capabilities into its lung stent offerings. This strategic move is likely to enhance patient outcomes by allowing for real-time data collection and analysis, thereby facilitating timely interventions. Such integration of technology into traditional medical devices signifies a shift towards more holistic patient care approaches, which could redefine treatment protocols in the lung stent sector. In September 2025, Abbott Laboratories (US) launched a new line of biodegradable lung stents, which are designed to dissolve after fulfilling their purpose. This innovation not only addresses the issue of long-term foreign body presence but also aligns with the growing trend towards sustainable medical solutions. The introduction of biodegradable options may attract environmentally conscious healthcare providers and patients, potentially reshaping market dynamics. In October 2025, Boston Scientific (US) unveiled a new digital platform aimed at enhancing the patient experience through personalized treatment plans and educational resources. This initiative reflects a broader trend towards digitalization in healthcare, where patient engagement and education are becoming paramount. By investing in digital tools, Boston Scientific (US) is likely to strengthen its competitive position and foster loyalty among healthcare providers and patients alike. As of October 2025, the Lung Stent Market is witnessing significant trends such as digital transformation, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a marked shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the lung stent market.

## Recent News & Developments

- **Q2 2024: Boston Scientific Announces FDA Approval of the AEROmini® Tracheobronchial Stent** Boston Scientific received FDA approval for its AEROmini® Tracheobronchial Stent, expanding its portfolio of minimally invasive airway management solutions for patients with tracheobronchial strictures.
- **Q1 2024: Merit Medical Systems Launches New Endotek® Silicone Airway Stent in the United States** Merit Medical Systems announced the commercial launch of its new Endotek® Silicone Airway Stent, designed to provide improved airway patency for patients with central airway obstruction.
- **Q2 2024: Taewoong Medical Receives CE Mark for Niti-S™ Tracheobronchial Stent** Taewoong Medical announced it has received CE Mark approval for its Niti-S™ Tracheobronchial Stent, allowing the product to be marketed and sold in the European Union.
- **Q2 2024: Cook Medical Announces Partnership with Medtronic to Distribute Airway Stent Portfolio in Asia-Pacific** Cook Medical entered into a distribution partnership with Medtronic to expand the reach of its airway stent products in the Asia-Pacific region.
- **Q1 2024: Micro-Tech Launches Next-Generation Covered Airway Stent in Europe** Micro-Tech (Nanjing) Co., Ltd. announced the European launch of its next-generation covered airway stent, designed for improved patient comfort and easier deployment.
- **Q2 2024: Boston Scientific Opens New Manufacturing Facility for Airway Stents in Ireland** Boston Scientific opened a new manufacturing facility in Ireland dedicated to the production of [airway stents](https://www.marketresearchfuture.com/reports/airway-stents-market-40694), aiming to meet growing global demand.
- **Q1 2024: Merit Medical Systems Appoints New Vice President of Airway Stent Division** Merit Medical Systems announced the appointment of a new Vice President to lead its Airway Stent Division, focusing on global expansion and innovation.
- **Q2 2024: Taewoong Medical Signs Distribution Agreement with Olympus for Lung Stent Market Products in Japan** Taewoong Medical signed a distribution agreement with Olympus to market and distribute its lung stent products in Japan.
- **Q1 2024: Cook Medical Receives FDA Clearance for Evolution® Biliary Stent for Airway Applications** Cook Medical received FDA clearance to market its Evolution® Biliary Stent for use in airway applications, expanding its therapeutic indications.
- **Q2 2024: Micro-Tech Announces $20 Million Investment to Expand Airway Stent Production Capacity** Micro-Tech (Nanjing) Co., Ltd. announced a $20 million investment to expand its airway stent production capacity at its main manufacturing site.

## Report Scope

| MARKET SIZE 2024 | 2.046(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 2.18(USD Billion) |
| MARKET SIZE 2035 | 4.12(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.57% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cook Medical (US), Terumo Corporation (JP), Stentys (FR), MediGlobe AG (DE), Stryker Corporation (US) |
| Segments Covered | Applications, Material, Procedure Type, Distribution Channel, Regional |
| Key Market Opportunities | Advancements in biocompatible materials enhance efficacy and patient outcomes in the Lung Stent Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the lung stent market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Lung Stent Market as of 2024?**
A: The Lung Stent Market was valued at 2.046 USD Billion in 2024.

**Q: What is the projected market size for the Lung Stent Market in 2035?**
A: The market is projected to reach 4.12 USD Billion by 2035.

**Q: What is the expected CAGR for the Lung Stent Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Lung Stent Market during 2025 - 2035 is 6.57%.

**Q: Which application segment is anticipated to have the highest valuation in 2035?**
A: Bronchial Stenting is expected to reach 1.68 USD Billion by 2035.

**Q: How do metal stents compare to polymer stents in terms of market valuation by 2035?**
A: By 2035, metal stents are projected to be valued at 1.64 USD Billion, while polymer stents are expected to reach 1.25 USD Billion.

**Q: What are the leading companies in the Lung Stent Market?**
A: Key players include Boston Scientific, Medtronic, Abbott Laboratories, and B. Braun Melsungen AG.

**Q: What is the anticipated market size for endoscopic procedures in 2035?**
A: Endoscopic procedures are projected to reach 2.48 USD Billion by 2035.

**Q: Which distribution channel is expected to show significant growth by 2035?**
A: Hospitals are anticipated to reach a valuation of 1.64 USD Billion by 2035.

**Q: What is the projected market size for tracheal stenting by 2035?**
A: Tracheal stenting is expected to reach 1.26 USD Billion by 2035.

**Q: How does the market for coated stents compare to that of polymer stents in 2035?**
A: Both coated stents and polymer stents are projected to reach 1.25 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/lung-stent-market-33081*